Table 5.
Changes in faecal secretory IgA (sIgA) and PGE2 levels in the placebo-controlled, double-blind, cross-over human feeding study with thirty-eight healthy human volunteers investigating the effects of Predilife (5 g/d) as compared with the placebo maltodextrin (5 g/d)
(Mean values and standard deviations)
| Baseline | Predilife treatment | Maltodextrin treatment | ||||
|---|---|---|---|---|---|---|
| Immunological parameter | Mean | sd | Mean | sd | Mean | sd |
| Faecal sIgA (µg/g) | 628·3 | 80·8 | 623·3 | 80·8 | 628·3 | 80·9 |
| Faecal PGE2 (pg/g) | 1124·9 | 143·7 | 984·8 | 132·1 | 1056·3 | 89·3 |